A detailed history of Gamma Investing LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Gamma Investing LLC holds 2,645 shares of DVAX stock, worth $32,507. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,645
Previous 960 175.52%
Holding current value
$32,507
Previous $10.8 Million 173.3%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$10.05 - $11.61 $16,934 - $19,562
1,685 Added 175.52%
2,645 $29.5 Million
Q2 2024

Jul 02, 2024

BUY
$10.73 - $12.58 $7,071 - $8,290
659 Added 218.94%
960 $10.8 Million
Q1 2024

Apr 05, 2024

BUY
$11.7 - $14.98 $772 - $988
66 Added 28.09%
301 $3.74 Million
Q4 2023

Feb 01, 2024

BUY
$13.09 - $14.98 $3,076 - $3,520
235 New
235 $3.04 Million

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.55B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.